Abstract     Description     Claims     Drawing  

J Clin Invest   [0001] 
Cell   [0001]  [0001] 
Circ Res   [0001] 
Science   [0001]  [0015] 
Stem Cells   [0001] 
PLoS ONE   [0001] 
Nature   [0001] 
Nature   [0001] 
Circ Res   [0001] 
N Engl J Med   [0001] 
Nature   [0001] 
Cardiovasc Res   [0002] 
FASEB J   [0002] 
Biotechnol Bioeng   [0002] 
Circ Res   [0002] 
Circ Res   [0002] 
Circ Res   [0002]  [0067] 
Am J Physiol Heart Circ Physiol   [0002] 
Tissue Eng Part A   [0003]  [0005] 
Circulation   [0005] 
Cell   [0015] 
J Clin Invest   [0015] 
Stem Cells Dev   [0063]  [0064] 
Cell Res   [0069] 
Nat Med   [0070] 
Differentiation   [0078] 
Nat Biotechnol   [0086] 
Stem Cells   [0088] 
Nat Biotechnol   [0089] 
Mol Biol Cell   [0089]  [0096] 
J Vis Exp   [0089] 
Cell Stem Cell   [0096] 
Circulation   [0096] 
Nature   [0096] 
Biotechnol Bioeng   [0101] 
Biotechnol Bioeng   [0102] 
Human embryonic stem cells can differentiate into myocytes with structural and functional properties of cardiomyocytes   [0105] 
Induction of pluripotent stem cells from adult human fibroblasts by defined factors   [0105] 
Functional cardiomyocytes derived from human induced pluripotent stem cells   [0105] 
Embryonic stem cell lines derived from human blastocysts   [0105]  [0105] 
Insulin Inhibits Cardiac Mesoderm, not Mesendoderm, formation during Cardiac Differentiation of Human Pluripotent Stem Cells and Modulation of Canonical Wnt Signaling Can Rescue this Inhibition   [0105] 
Human engineered heart tissue as a versatile tool in basic research and preclinical toxicology   [0105] 
Patient-specific induced pluripotent stem-cell-derived models of LEOPARD syndrome   [0105] 
Modelling the long QT syndrome with induced pluripotent stem cells   [0105] 
Cardiomyocytes obtained from induced pluripotent stem cells with long-QT syndrome 3 recapitulate typical disease-specific features In Vitro   [0105] 
Patient-specific induced pluripotent stem-cell models for long-QT syndrome   [0105] 
Using induced pluripotent stem cells to investigate cardiac phenotypes in Timothy syndrome   [0105] 
The human adult cardiomyocyte phenotype   [0105] 
Three-dimensional reconstitution of embryonic cardiomyocytes in a collagen matrix: a new heart muscle model system   [0105] 
Tissue engineering of a differentiated cardiac muscle construct   [0105] 
Growth of engineered human myocardium with mechanical loading and vascular coculture   [0105] 
Terminal differentiation, advanced organotypic maturation, and modeling of hypertrophic growth in engineered heart tissue   [0105] 
Physiological aspects of cardiac tissue engineering   [0105] 
Development of myocardial constructs using modulus-matched acrylated polypropylene glycol triol substrate and different nonmyocyte cell populations   [0105] 
Primitive cardiac cells from human embryonic stem cells   [0105] 
Ascorbic acid enhances the cardiac differentiation of induced pluripotent stem cells through promoting the proliferation of cardiac progenitor cells   [0105] 
TGFbeta and BMP signaling in cardiac cushion formation: lessons from mice and chicken   [0105] 
Analysis of oxygen transport in a diffusion-limited model of engineered heart tissue   [0105] 
Facilitated expansion of human embryonic stem cells by single-cell enzymatic dissociation   [0105] 
Live cell imaging distinguishes bona fide human iPS cells from partially reprogrammed cells   [0105] 
Epigenetic reprogramming of OCT4 and NANOG regulatory regions by embryonal carcinoma cell extract   [0105] 
Chromosomal spread preparation of human embryonic stem cells for karyotyping   [0105] 
Stage-specific optimization of activin/nodal and BMP signaling promotes cardiac differentiation of mouse and human pluripotent stem cell lines   [0105] 
Titin isoform switch in ischemic human heart disease   [0105] 
Reprogramming of human somatic cells to pluripotency with defined factors   [0105] 
Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors   [0105] 
Parthenogenetic stem cells for tissue-engineered heart repair   [0105] 
Identification and targeting of the ROSA26 locus in human embryonic stem cells   [0105] 
Optimizing engineered heart tissue for therapeutic applications as surrogate heart muscle   [0105] 
Three-dimensional engineered heart tissue from neonatal rat cardiac myocytes   [0105] 
Engineered heart tissue grafts improve systolic and diastolic function in infarcted rat hearts   [0105]